pazufloxacin mesylate
Active Pharmaceutical Ingredients 2025-03-03
Catalog ID80020455
CAS NO.163680-77-1
Purity 96%
MDL NumberMFCD00913262
Molecular Formula C17H19FN2SO7
Molecular Weight 414.4
Melting point: >255°C
| Category | Information |
|---|---|
| Chemical Properties | – Molecular Formula: C₁₇H₁₉FN₂O₇S<br>- Molecular Weight: 414.41 g/mol |
| Physical Properties | – Appearance: White to off-white powder<br>- Solubility: Soluble in water (≥ 100 mg/mL) and DMSO (100 mg/mL, with sonication) |
| Mechanism of Action | – Fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV.<br>- Exhibits broad-spectrum antibacterial activity against Gram-positive and Gram-negative bacteria, including quinolone-resistant strains. |
| Clinical Uses | – Respiratory Infections: Chronic bronchitis, pneumonia, lung abscess.<br>- Urinary Tract Infections: Pyelonephritis, complicated cystitis.<br>- Gynecological Infections: Pelvic inflammatory disease, endometritis.<br>- Surgical and Burn Infections: Wound infections, burn surface infections.<br>- Gastrointestinal Infections: Cholecystitis, cholangitis, intra-abdominal abscess. |
| Dosage | – Adults: Intravenous infusion, 0.5 g twice daily, or 0.3 g twice daily for mild cases.<br>- Duration: Typically 7-14 days. |
| Adverse Effects | – Common: Nausea, headache, dizziness.<br>- Rare: Allergic reactions, liver function abnormalities. |
| Contraindications | – Hypersensitivity to pazufloxacin or other quinolones.<br>- Pregnancy and breastfeeding.<br>- Children. |
| Storage Conditions | Store at 4°C, sealed, away from moisture. |
| Synonyms | – Pazufloxacin methanesulfonate<br>- T-3762<br>- Pazucross |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
